Search results
Johnson & Johnson is restoring the true meaning of healthcare by developing advanced treatments and smarter and less invasive solutions for today’s most complex diseases.
- Investor
The J&J value. At Johnson & Johnson, we believe health is...
- About J&J
At Johnson & Johnson, we believe health is everything. Our...
- Products
Johnson & Johnson Innovative Medicine is leading where...
- Careers
Johnson & Johnson is an Affirmative Action and Equal...
- Personal Stories
Read all Johnson & Johnson personal stories . Nina...
- Health & Wellness
Read all stories from J&J about health and wellness . Skip...
- Our Heritage
4 Innovative Ways Johnson & Johnson Has Helped Protect the...
- Suppliers
Just as we believe that good health is the foundation of...
- Investor
Hace 3 días · Corporate reports. Here are some of the print and digital publications we produce each year that recap the company’s business performance and key enterprise-wide milestones.
30 de may. de 2024 · Artist: J.J. Johnson Album: First Place Genre: Bop Label: Columbia/Sony Music Japan Released: 1957/2015 Quality: FLAC (tracks+.cue) Tracklist: It's Only A.
28 de may. de 2024 · NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) announced today it has entered into a definitive agreement with Numab Therapeutics, a clinical-stage biotechnology company advancing a pipeline of immunology and oncology therapeutics, to acquire from Numab's shareholders its wholly-owned subsidiary for the global ...
Hace 5 días · Johnson & Johnson ha desvelado su nueva identidad visual de marca, con la que la compañía da comienzo a una nueva etapa estratégica que refleja su enfoque en la innovación en el terreno de la atención médica y el cuidado de la salud.
Hace 4 días · Johnson & Johnson must pay $260 million to an Oregon woman who said she got mesothelioma, a deadly cancer linked to asbestos exposure, from inhaling the company's talc powder, a jury found on Monday.
28 de may. de 2024 · Johnson & Johnson on Tuesday agreed to acquire the rights to an experimental skin disorder treatment from privately held Numab Therapeutics for about $1.25 billion, its second deal for an...